The supermodel has thrown in the towel and closed down the company less than three years after it was launched to great ...

The skin is the largest organ of the body, and works as a protective shield against the outside world. It protects us, and ...

Deucravacitinib met its primary endpoint of more than 20% improvement in ACR20 response among patients with psoriatic ...

Patients with psoriatic arthritis (PsA) have a higher prevalence of diabetes mellitus (DM) compared to the general population ...

A recent study reveals a link between belly fat and psoriasis, especially in women. Researchers analyzed data from UK Biobank ...

Psoriasis and rheumatoid arthritis are both autoimmune conditions, and it’s possible to have both at once. It’s more common to have psoriatic arthritis along with psoriasis.

A rare case of adalimumab-induced pustular psoriasis in a hidradenitis suppurativa patient was successfully treated with ...

The autoimmune disease causes raised, scaly patches of skin. As a child, it left the football star embarrassed to remove his ...

Modifiable lifestyle factors significantly affect the incidence of psoriatic disease, cardiometabolic comorbidities, and all-cause mortality.

Psoriasis affects your body’s immune system, causing it to produce too many skin cells. Those extra cells build up and create a flaky rash that may appear red, purple, ashen gray, or brown ...

Psoriasis occurs in people of all ages but is primarily seen in adults, with the highest proportion between ages 45 and 64. (32) Psoriasis affects nearly 7.5 million people in the United States.

Objective To evaluate the efficacy and safety of an oral selective tyrosine kinase 2 (TYK2) inhibitor, deucravacitinib, in patients with active psoriatic arthritis (PsA). Methods In this double-blind, ...